{"Beilstein Registry Numbers": ["3905622"], "CAS Registry Numbers": ["312-48-1"], "ChEBI ID": 251408, "ChEBI Name": "edrophonium", "Charge": 1, "Definition": "A quaternary ammonium ion that is <element>N</element>-ethyl-<element>N</element>,<element>N</element>-dimethylanilinium in which one of the <ital>meta</ital> positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.", "DrugBank Database Links": ["DB01010"], "Formulae": ["C10H16NO"], "IUPAC Names": ["N-ethyl-3-hydroxy-N,N-dimethylanilinium"], "InChI": ["InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1"], "InChIKey": ["VWLHWLSRQJQWRG-UHFFFAOYSA-O"], "KEGG COMPOUND Database Links": ["C06976"], "LINCS Database Links": ["LSM-5867"], "Mass": 166.2401, "Molfile": "\n  Marvin  07261011182D          \n\n 12 12  0  0  0  0            999 V2000\n    4.8295   -4.9749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.8295   -5.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.1150   -4.5624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.1150   -6.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.4006   -4.9749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.4006   -5.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.6861   -4.5624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.5440   -4.5623    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0\n    6.2585   -4.9748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.9730   -4.5623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.9539   -3.8467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.1389   -3.8467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  0  0  0  0\n  3  1  2  0  0  0  0\n  4  2  2  0  0  0  0\n  5  3  1  0  0  0  0\n  6  4  1  0  0  0  0\n  6  5  2  0  0  0  0\n  5  7  1  0  0  0  0\n  1  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n  8 11  1  0  0  0  0\n  8 12  1  0  0  0  0\nM  CHG  1   8   1\nM  END", "Monoisotopic Mass": 166.12264, "PDBeChem Database Links": ["EDR"], "PubChem Database Links": ["CID: 3202", "SID: 87350897"], "PubMed Citation Links": ["7488499"], "SABIO-RK Database Links": ["7923", "8101", "8103", "8104", "8106"], "SMILES": ["CC[N+](C)(C)c1cccc(O)c1"], "Secondary ChEBI ID": ["CHEBI:42376", "CHEBI:4758"], "Star": 3, "Synonyms": ["(3-hydroxyphenyl)dimethylethylammonium", "3-hydroxy-N,N-dimethyl-N-ethylanilinium", "EDROPHONIUM", "EDROPHONIUM ION", "Edrophonium", "Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium", "N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium", "edrophonium"]}
{"Beilstein Registry Numbers": ["577108"], "CAS Registry Numbers": ["37115-32-5"], "ChEBI ID": 251412, "ChEBI Name": "adinazolam", "Charge": 0, "Definition": "A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position.", "DrugBank Database Links": ["DB00546"], "Formulae": ["C19H18ClN5"], "INN": ["adinazolam", "adinazolamum"], "IUPAC Names": ["1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine"], "InChI": ["InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3"], "InChIKey": ["GJSLOMWRLALDCT-UHFFFAOYSA-N"], "KEGG DRUG Database Links": ["D02770"], "Mass": 351.833, "Molfile": "\n          11280715132D 1   1.00000     0.00000     0\n\n 25 28  0     0  0            999 V2000\n    0.6792   -2.3250    0.0000 N   0  0  3  0  0  0           0  0  0\n    0.6000   -1.5125    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.0292   -2.8375    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.0292   -3.6667    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.3625   -1.1875    0.0000 N   0  0  0  0  0  0           0  0  0\n    1.4792   -2.4917    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.8875   -1.7792    0.0000 N   0  0  0  0  0  0           0  0  0\n    0.6792   -4.1792    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.4792   -4.0042    0.0000 N   0  0  0  0  0  0           0  0  0\n    1.8375   -3.2750    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.6833   -2.4167    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.1333   -1.0792    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.6833   -4.0667    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.6792   -5.0042    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.1333   -0.2625    0.0000 N   0  0  3  0  0  0           0  0  0\n   -1.4000   -3.6542    0.0000 C   0  0  0  0  0  0           0  0  0\n   -1.4000   -2.8500    0.0000 C   0  0  0  0  0  0           0  0  0\n   -2.1458   -4.0542    0.0000 Cl  0  0  0  0  0  0           0  0  0\n   -0.0458   -5.4167    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.3792   -5.4167    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.8250    0.1458    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.6167    0.1375    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.3792   -6.2417    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.0458   -6.2417    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.6792   -6.6625    0.0000 C   0  0  0  0  0  0           0  0  0\n  2  1  1  0     0  0\n  3  1  1  0     0  0\n  4  3  2  0     0  0\n  5  2  2  0     0  0\n  6  1  1  0     0  0\n  7  6  2  0     0  0\n  8  4  1  0     0  0\n  9 10  1  0     0  0\n 10  6  1  0     0  0\n 11  3  1  0     0  0\n 12  2  1  0     0  0\n 13  4  1  0     0  0\n 14  8  1  0     0  0\n 15 12  1  0     0  0\n 16 17  1  0     0  0\n 17 11  2  0     0  0\n 18 16  1  0     0  0\n 19 14  1  0     0  0\n 20 14  2  0     0  0\n 21 15  1  0     0  0\n 22 15  1  0     0  0\n 23 20  1  0     0  0\n 24 19  2  0     0  0\n 25 23  2  0     0  0\n  5  7  1  0     0  0\n  8  9  2  0     0  0\n 13 16  2  0     0  0\n 24 25  1  0     0  0\nM  END", "Monoisotopic Mass": 351.12507, "Patent Database Links": ["DE2201210", "GB1393256", "US4250094"], "PubChem Database Links": ["CID: 37632", "SID: 85444484"], "SMILES": ["CN(C)Cc1nnc2CN=C(c3ccccc3)c3cc(Cl)ccc3-n12"], "Star": 3, "Synonyms": ["8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine"]}
{"Beilstein Registry Numbers": ["7140558"], "CAS Registry Numbers": ["122852-42-0"], "ChEBI ID": 253342, "ChEBI Name": "alosetron", "Charge": 0, "Definition": "A pyrido[4,3-<ital>b</ital>]indole compound having a 5-methyl-1<element>H</element>-imidazol-4-ylmethyl group at the 2-position.", "DrugBank Database Links": ["DB00969"], "Formulae": ["C17H18N4O"], "INN": ["alosetron"], "IUPAC Names": ["5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one"], "InChI": ["InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)"], "InChIKey": ["JSWZEAMFRNKZNL-UHFFFAOYSA-N"], "KEGG DRUG Database Links": ["D07129"], "LINCS Database Links": ["LSM-5576"], "Mass": 294.351, "Molfile": " \n  Marvin  12100911412D          \n\n 22 25  0  0  0  0            999 V2000\n   15.4267  -10.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.4267  -11.2926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1377  -11.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.8488  -11.2926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.8488  -10.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1377  -10.0378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1377  -12.5475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   17.6854  -11.5436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.1455  -10.8743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.6854  -10.1633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   18.0200  -12.2965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.8566  -12.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.3167  -11.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.9820  -10.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.6738  -11.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.9627  -11.2926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.9364   -9.3686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.9627  -10.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.6738  -10.0378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.1680  -10.2051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.7079  -10.8743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.1680  -11.5436    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  2  0  0  0  0\n  5  6  1  0  0  0  0\n  1  6  1  0  0  0  0\n  3  7  2  0  0  0  0\n  4  8  1  0  0  0  0\n  8  9  1  0  0  0  0\n  9 10  1  0  0  0  0\n  5 10  1  0  0  0  0\n  8 11  2  0  0  0  0\n 11 12  1  0  0  0  0\n 12 13  2  0  0  0  0\n 13 14  1  0  0  0  0\n  9 14  2  0  0  0  0\n  2 15  1  0  0  0  0\n 15 16  1  0  0  0  0\n 10 17  1  0  0  0  0\n 16 18  2  0  0  0  0\n 18 19  1  0  0  0  0\n 18 20  1  0  0  0  0\n 20 21  1  0  0  0  0\n 21 22  2  0  0  0  0\n 16 22  1  0  0  0  0\nM  END", "Monoisotopic Mass": 294.14806, "Patent Database Links": ["EP306323", "US5360800"], "PubChem Database Links": ["CID: 2099", "SID: 85446390"], "SMILES": ["Cc1[nH]cnc1CN1CCc2c(C1=O)c1ccccc1n2C"], "Star": 3, "Synonyms": ["2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one"], "Wikipedia Database Links": ["Alosetron"]}
{"Beilstein Registry Numbers": ["1912135"], "CAS Registry Numbers": ["57-97-6"], "ChEBI ID": 254496, "ChEBI Name": "7,12-dimethyltetraphene", "Charge": 0, "Definition": "A tetraphene having methyl substituents at the 7- and 12-positions. It is a potent carcinogen and is present in tobacco smoke.", "Formulae": ["C20H16"], "Gmelin Registry Numbers": ["263937"], "IUPAC Names": ["7,12-dimethylbenzo[a]anthracene"], "InChI": ["InChI=1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3"], "InChIKey": ["ARSRBNBHOADGJU-UHFFFAOYSA-N"], "KEGG COMPOUND Database Links": ["C19488"], "LINCS Database Links": ["LSM-37159"], "Mass": 256.341, "Molfile": "\n          11280715142D 1   1.00000     0.00000     0\n\n 20 23  0     0  0            999 V2000\n    1.7542   -7.7375    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.7625   -8.5667    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.0417   -7.3292    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.0500   -8.9792    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.3292   -7.7417    0.0000 C   0  0  0  0  0  0           0  0  0\n    0.3292   -8.5667    0.0000 C   0  0  0  0  0  0           0  0  0\n    2.4667   -7.3125    0.0000 C   0  0  0  0  0  0           0  0  0\n    2.4792   -8.9750    0.0000 C   0  0  0  0  0  0           0  0  0\n    3.1875   -7.7167    0.0000 C   0  0  0  0  0  0           0  0  0\n    3.2000   -8.5500    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.0375   -6.5042    0.0000 C   0  0  0  0  0  0           0  0  0\n    1.0500   -9.8042    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.3833   -7.3292    0.0000 C   0  0  0  0  0  0           0  0  0\n   -0.3833   -8.9875    0.0000 C   0  0  0  0  0  0           0  0  0\n    2.4542   -6.4917    0.0000 C   0  0  0  0  0  0           0  0  0\n    3.8917   -7.2917    0.0000 C   0  0  0  0  0  0           0  0  0\n   -1.0958   -7.7500    0.0000 C   0  0  0  0  0  0           0  0  0\n   -1.0958   -8.5750    0.0000 C   0  0  0  0  0  0           0  0  0\n    3.1625   -6.0667    0.0000 C   0  0  0  0  0  0           0  0  0\n    3.8875   -6.4667    0.0000 C   0  0  0  0  0  0           0  0  0\n  2  1  1  0     0  0\n  3  1  2  0     0  0\n  4  2  2  0     0  0\n  5  3  1  0     0  0\n  6  5  1  0     0  0\n  7  1  1  0     0  0\n  8  2  1  0     0  0\n  9  7  1  0     0  0\n 10  9  1  0     0  0\n 11  3  1  0     0  0\n 12  4  1  0     0  0\n 13  5  2  0     0  0\n 14  6  2  0     0  0\n 15  7  2  0     0  0\n 16  9  2  0     0  0\n 17 13  1  0     0  0\n 18 17  2  0     0  0\n 19 15  1  0     0  0\n 20 19  2  0     0  0\n  8 10  2  0     0  0\n  6  4  1  0     0  0\n 16 20  1  0     0  0\n 18 14  1  0     0  0\nM  END", "Monoisotopic Mass": 256.1252, "PubChem Database Links": ["CID: 6001", "SID: 85447540"], "PubMed Citation Links": ["11488430", "12839762", "16020197", "18992763", "7561049"], "SMILES": ["Cc1c2ccccc2c(C)c2c1ccc1ccccc21"], "Secondary ChEBI ID": ["CHEBI:59032"], "Star": 3, "Synonyms": ["1,4-Dimethyl-2,3-benzphenanthrene", "6,7-Dimethyl-1,2-benzanthracene", "7,12-DMBA", "7,12-Dimethyl-1,2-benzanthracene", "7,12-Dimethyl-1:2-benz(a)anthracene", "7,12-Dimethylbenz(a)anthracene", "7,12-Dimethylbenzanthracene", "7,12-Dimethylbenzanthrancene", "7,12-dimethylbenzo[a]anthracene", "9,10-Dimethyl-1,2-benzanthracene", "9,10-Dimethyl-1,2-benzanthrazen", "9,10-Dimethylbenz(a)anthracene", "DMBA"], "UniProt Database Links": ["O54992", "P85278", "Q8CE22"]}
